hotspot -WSS

hotspot

author：focus 2025-09-30 00:39:35 - browse：7374

AstraZeneca said Friday it will buy up a group of early-stage gene therapies from Pfizer, bucking a trend of drugmakers axing programs and exiting a field that had once captured the imagination — and checkbooks — of many pharmaceutical executives.

AstraZeneca will pay Pfizer up to $1 billion plus royalties for the portfolio of treatments, none of which has entered clinical trials yet. The companies did not say how much it is paying upfront.

The moves come six months after Pfizer said it would stop much of its work on early-stage gene therapy programs, in which researchers try to deliver replacement genes encased in small, non-pathogenic bugs called adeno-associated viruses, or AAVs. Instead, it would focus on newer technologies, such as gene editing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Illumina to lay off 10% of research and development team

hotspot

focus

knowledge

WSS

Boeing's 1st astronaut flight bumped into next year, more repairs needed

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

Appeals court upholds Josh Duggar's conviction for downloading child sex abuse images

hotspot

hotspot

leisure time

Psychedelics group wrestles with new pharma identity

ADA: All diabetes patients should be screened for liver condition

The cancer drug shortage isn’t new — and neither are the solutions

Illinois to ban advertising for guns allegedly marketed to kids and militants

Continuity nursing helped my family in our darkest PICU moments

Prince Harry seeks over $550,000 in phone hacking lawsuit against British tabloid publisher

Virginia high school admissions case could be legal follow

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

Trump demands the U.S. pay no more for drugs than other countries … again

The strange history of BMI, the body mass index

focus

Medical experts exlpore how to eliminate bias in clinical algorithms

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

Medical experts exlpore how to eliminate bias in clinical algorithms

Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

hotspot

focus

knowledge

knowledge